The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 09, 2016

Filed:

Mar. 15, 2013
Applicant:

University of Vermont, Burlington, VT (US);

Inventor:

Peter S. Spector, Burlington, VT (US);

Assignee:

University of Vermont, Burlington, VT (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61B 5/04 (2006.01); A61B 5/042 (2006.01); A61B 5/046 (2006.01); A61B 18/14 (2006.01); A61B 19/00 (2006.01);
U.S. Cl.
CPC ...
A61B 5/04014 (2013.01); A61B 5/046 (2013.01); A61B 5/04017 (2013.01); A61B 5/0422 (2013.01); A61B 18/14 (2013.01); A61B 18/1492 (2013.01); A61B 19/5244 (2013.01); A61B 2019/5251 (2013.01); A61B 2562/046 (2013.01);
Abstract

Methods and systems for using feedback to minimize and treat cardiac fibrillation in a patient, includes generating a map of one or more measurements indicative of a number and distribution of electrical circuit cores for a duration across a cardiac tissue substrate in the patient's heart in response to electrical activity, defining an optimal placement of at least one ablation lesion in the cardiac tissue substrate; applying ablation lesion therapy based on the optimal placement; determining whether the ablation lesion therapy minimized or treated cardiac fibrillation; if therapy is determined to have minimized or treated cardiac fibrillation, assessing fibrillogenicity of the cardiac tissue substrate to determine whether fibrillogenicity is below a predetermined threshold; and if therapy is determined to have not minimized or treated cardiac fibrillation, repeating the steps of generating, defining, applying, and determining until ablation lesion therapy minimizes or treats cardiac fibrillation.


Find Patent Forward Citations

Loading…